Normal wound healing is a tightly orchestrated relay race. When tissue is damaged, the body moves sequentially through distinct phases: inflammation clears out debris and pathogens, proliferation rebuilds the tissue matrix and blood vessels, and remodeling restores structural integrity.
In patients with diabetes, this relay race grinds to a halt. Hyperglycemia drops the baton, trapping the wound in a self-perpetuating, hostile microenvironment. As described by Qian Gao et al. in Multifunctional hydrogel with mild photothermal properties enhances diabetic wound repair by targeting MRSA energy metabolism, this pathological state is defined by persistent inflammation, high glucose levels, and intense oxidative stress. Instead of transitioning to tissue repair, the wound becomes a stagnant biological bottleneck that permits opportunistic infections to thrive, frequently culminating in chronic diabetic foot ulcers and lower-limb amputations.
To break this cycle, a major research direction has emerged focusing on microenvironment remodeling. Rather than treating the wound superficially, researchers are developing advanced biomaterials and cell-free therapies designed to rewrite corrupt cellular signaling, clear oxidative stress, and jumpstart the stalled healing cascade.
The Cellular Bottleneck: Senescence, Ferroptosis, and Signal Corruption
To understand why diabetic wounds fail to heal, we must look at how chronic hyperglycemia alters cellular behavior and survival at the zone of injury.
Cellular Senescence
Dermal fibroblasts and endothelial cells are the primary architects of wound closure and angiogenesis (the growth of new blood vessels). Under high-glucose conditions, these cells are forced into a state of premature aging, or senescence. Wei Qian et al. demonstrate in MiR‐17‐5p‐engineered sEVs Encapsulated in GelMA Hydrogel Facilitated Diabetic Wound Healing by Targeting PTEN and p21 that this hyperglycemia-induced senescence severely impairs the cells' ability to proliferate and migrate, effectively leaving the wound without the cellular machinery required to build new tissue.
Ferroptosis
Cells within the diabetic wound are not just inactive; they are actively dying through a specialized, iron-dependent programmed cell death pathway called ferroptosis. Research by Zhen Liang et al. in FGF21-engineered ADSCs promote diabetic wound healing by mitigating ferroptosis and oxidative stress via the SIRT1/NRF2/GPX4 signaling pathway reveals that the hyperglycemic environment triggers iron accumulation, mitochondrial damage, and lipid peroxidation. This widespread cellular loss permanently stalls the transition from the inflammatory phase to the proliferative phase of repair.
Immune Imbalance and Corrupted Communication
The local immune response becomes severely dysregulated. Xiajun Liang et al. established in Neutrophil Extracellular Trap-Related Genes and Immune Infiltration in Diabetic Foot Ulcers by Bioinformatics Analysis and Experimental Verification that the high-glucose environment causes an influx of inflammatory neutrophils. These cells release Neutrophil Extracellular Traps (NETs)—networks of extracellular DNA that, while meant to trap pathogens, end up paralyzing the fibroblasts and T cells essential for healing.
Furthermore, the lines of communication between cells become corrupted. Xiaowei Bian et al. discovered in Extracellular vesicles derived from fibroblasts induced with or without high glucose exert opposite effects on wound healing and angiogenesis that extracellular vesicles (EVs) secreted by fibroblasts under high-glucose conditions actively suppress angiogenesis via the GSK-3β/β-catenin pathway. A signal that should promote blood vessel growth is inverted into an inhibitory command.
[Hyperglycemia]
│
├─► Cellular Senescence (Stops fibroblast & endothelial migration)
├─► Ferroptosis (Iron accumulation & mitochondrial death)
├─► Neutrophil Influx & NETs (Persistent inflammatory arrest)
└─► Corrupted EV Signaling (Suppresses angiogenesis)
│
[Stalled Wound Healing / Chronic Ulcer]
Rejuvenating the Microenvironment via Cell-Free Therapies
If the primary barrier to healing is corrupted cellular programming, the solution is to deliver new, corrective instructions. Researchers are leveraging engineered extracellular vesicles (EVs) and exosomes as cell-free therapies to act as molecular "switches" that reset the wound environment.
These nano-sized vesicles can penetrate damaged tissues to deliver targeted microRNAs or proteins directly into senescent or damaged cells:
- Reversing Senescence: Jianlong Su et al. show in P-MSC-derived extracellular vesicles facilitate diabetic wound healing via miR-145-5p/ CDKN1A-mediated functional improvements of high glucose-induced senescent fibroblasts that placental mesenchymal stem cell EVs loaded with miR-145-5p can rescue senescent fibroblasts. They achieve this by downregulating the senescence marker CDKN1A and activating the Erk/Akt signaling pathway, restoring the cells' proliferative and migratory capacities.
- Modulating Inflammation: Rather than using broad anti-inflammatory drugs, Yongxiang Zhang et al. demonstrated in Exosomal coactivator-associated arginine methyltransferase 1 derived from adipocytes accelerates diabetic wound healing by modulating inflammation and promoting angiogenesis that adipocyte-derived exosomes carrying the Carm1 protein function as an epigenetic switch. These exosomes systematically reduce persistent inflammation while simultaneously kickstarting the growth of new blood vessels.
Pathology-Responsive Biomaterials as Active Regulators
While cell-free therapies provide the instructions for repair, they require a supportive vehicle to survive the harsh, enzyme-rich environment of a chronic wound. Traditional passive dressings like gauze merely cover a wound; modern diabetic wound care relies on pathology-responsive biomaterials that actively interact with the tissue.
As highlighted by Yingshui Yao et al. in Emerging Biomedical Engineering Therapies for Infected Diabetic Foot Ulcers: Toward Antibacterial Functionalization and Pathology‐Responsive Regulation, advanced hydrogels are engineered to sense localized pathological cues such as altered pH, elevated glucose levels, and high concentrations of reactive oxygen species (ROS).
Dynamic Drug Release
Instead of dumping their therapeutic payload all at once, these smart hydrogels change their physical structure in response to the wound's state. For example, Jing Guo et al. developed a thermo-sensitive hydrogel in Wound Microenvironment Self-Adjusting Hydrogels with Thermo-Sensitivity for Promoting Diabetic Wound Healing that dynamically self-adjusts to the wound site, releasing therapeutic agents precisely when and where they are needed based on localized environmental shifts.
Active Tissue Penetration
Chronic wounds often feature dense, necrotic tissue and resilient bacterial biofilms that prevent passive drugs from reaching deep-seated injuries. To overcome this, Chengqi Yan et al. designed magnetically controlled biohybrid nanorobots in Biohybrid Nanorobots Carrying Glycoengineered Extracellular Vesicles Promote Diabetic Wound Repair through Dual‐Enhanced Cell and Tissue Penetration. These nanorobots actively navigate and penetrate deep into the complex wound matrix, delivering antioxidant-loaded EVs directly to the compromised cells at the base of the ulcer.
By combining responsive material scaffolds with targeted molecular therapies, this research direction shifts the clinical paradigm from basic wound coverage to active, intelligent microenvironmental remodeling—reversing cellular senescence, halting ferroptosis, and clearing the path for natural tissue regeneration.
Key Foundational Work
Sensing, monitoring, and release of therapeutics: the translational journey of next generation bandages (2018) — contributed 1 concept elements to this direction.
Cytotoxicity and wound healing properties of PVA/ws-chitosan/glycerol hydrogels made by irradiation followed by freeze–thawing (2010) — contributed 1 concept elements to this direction.